The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 2041 -2045
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dominitzki, S.
Right arrow Articles by Becker, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dominitzki, S.
Right arrow Articles by Becker, C.

Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25 T Cells1

Sabine Dominitzki2,*, Massimo C. Fantini2,{dagger}, Clemens Neufert*, Alexei Nikolaev*, Peter R. Galle*, Jürgen Scheller{ddagger}, Giovanni Monteleone{dagger}, Stefan Rose-John{ddagger}, Markus F. Neurath3,* and Christoph Becker3,4,*

* Laboratory of Immunology, Medical Clinic I, University of Mainz, Mainz, Germany; {dagger} Department of Internal Medicine, University of Rome "Tor Vergata", Rome, Italy; and {ddagger} Department of Biochemistry, University of Kiel, Kiel, Germany

Chronic inflammatory diseases may develop when regulatory T cells (Tregs) fail to control the balance between tolerance and immunity. Alternatively, activated immune cells might prevent the induction or activation of Tregs in such diseases. In this study, we demonstrate that trans-signaling into T cells via the soluble IL-6 receptor completely abrogates the de novo induction of adaptive Tregs. Mechanistically, IL-6 trans-signaling augmented the expression of the TGF-beta signaling inhibitor SMAD7. Consequently, SMAD7 overexpression in T cells using newly created transgenic mice rendered CD4+CD25 T cells resistant to the induction of FoxP3. Finally, IL-6 trans-signaling inhibited Treg-mediated suppression in a murine model of colitis. In summary, IL-6 trans-signaling into T cells emerges as a key pathway for blockade of the development of adaptive Tregs and thus may play a pivotal role in shifting the balance between effector and regulatory T cell numbers in chronic inflammatory and autoimmune diseases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the collaborative research grant SFB548 from the Deutsche Forschungsgemeinschaft (to C.B. and M.F.N.).

2 S.D. and M.C.F. share first authorship.

3 M.F.N. and C.B. share senior authorship.

4 Address correspondence and reprint requests to Dr. Christoph Becker, Laboratory of Immunology, Medical Clinic I, University of Mainz, Obere Zahlbacher Strasse 63, 55131 Mainz, Germany. E-mail address: chbecker{at}uni-mainz.de

5 Abbreviations used in this paper: Treg, regulatory T cell; HA, hemagglutinin; HA-TCRtg/RAG, transgenic for HA-specific TCR (mice); HIL-6, Hyper-IL-6; HPRT, hypoxanthine phosphoribosyltransferase; iTreg, induced Treg; sIL-6R, soluble IL-6R.




This article has been cited by other articles:


Home page
BloodHome page
G. Lal and J. S. Bromberg
Epigenetic mechanisms of regulation of Foxp3 expression
Blood, October 29, 2009; 114(18): 3727 - 3735.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Turner, L. P. Kane, and P. A. Morel
Dominant Role of Antigen Dose in CD4+Foxp3+ Regulatory T Cell Induction and Expansion
J. Immunol., October 15, 2009; 183(8): 4895 - 4903.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wang, T. W. J. Huizinga, and R. E. M. Toes
De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid
J. Immunol., September 15, 2009; 183(6): 4119 - 4126.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Baban, P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
J. Immunol., August 15, 2009; 183(4): 2475 - 2483.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Brahmachari and K. Pahan
Suppression of Regulatory T Cells by IL-12p40 Homodimer via Nitric Oxide
J. Immunol., August 1, 2009; 183(3): 2045 - 2058.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. A. Neveu, J. B. Allard, O. Dienz, M. J. Wargo, G. Ciliberto, L. A. Whittaker, and M. Rincon
IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens
J. Immunol., August 1, 2009; 183(3): 1732 - 1738.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Chen, R. Das, R. Komorowski, A. Beres, M. J. Hessner, M. Mihara, and W. R. Drobyski
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
Blood, July 23, 2009; 114(4): 891 - 900.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Monari, S. Bevilacqua, M. Piccioni, E. Pericolini, S. Perito, M. Calvitti, F. Bistoni, T. R. Kozel, and A. Vecchiarelli
A Microbial Polysaccharide Reduces the Severity of Rheumatoid Arthritis by Influencing Th17 Differentiation and Proinflammatory Cytokines Production
J. Immunol., July 1, 2009; 183(1): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Nowell, A. S. Williams, S. A. Carty, J. Scheller, A. J. Hayes, G. W. Jones, P. J. Richards, S. Slinn, M. Ernst, B. J. Jenkins, et al.
Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
J. Immunol., January 1, 2009; 182(1): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Duan, T. So, and M. Croft
Antagonism of Airway Tolerance by Endotoxin/Lipopolysaccharide through Promoting OX40L and Suppressing Antigen-Specific Foxp3+ T Regulatory Cells
J. Immunol., December 15, 2008; 181(12): 8650 - 8659.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Samanta, B. Li, X. Song, K. Bembas, G. Zhang, M. Katsumata, S. J. Saouaf, Q. Wang, W. W. Hancock, Y. Shen, et al.
TGF-{beta} and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3
PNAS, September 16, 2008; 105(37): 14023 - 14027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. E. Sander, F. Obermeier, U. Dierssen, D. C. Kroy, A. K. Singh, U. Seidler, K. L. Streetz, H. H. Lutz, W. Muller, F. Tacke, et al.
Gp130 Signaling Promotes Development of Acute Experimental Colitis by Facilitating Early Neutrophil/Macrophage Recruitment and Activation
J. Immunol., September 1, 2008; 181(5): 3586 - 3594.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M. Briso, O. Dienz, and M. Rincon
Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells
J. Immunol., June 1, 2008; 180(11): 7102 - 7106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Zheng, J. Wang, and D. A. Horwitz
Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-{beta} Are Resistant to Th17 Conversion by IL-6
J. Immunol., June 1, 2008; 180(11): 7112 - 7116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. P. Sarangi, S. Sehrawat, S. Suvas, and B. T. Rouse
IL-10 and Natural Regulatory T Cells: Two Independent Anti-Inflammatory Mechanisms in Herpes Simplex Virus-Induced Ocular Immunopathology
J. Immunol., May 1, 2008; 180(9): 6297 - 6306.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Rabe, A. Chalaris, U. May, G. H. Waetzig, D. Seegert, A. S. Williams, S. A. Jones, S. Rose-John, and J. Scheller
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Blood, February 1, 2008; 111(3): 1021 - 1028.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.